These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6407052)

  • 21. Effects of fusaric acid on the membrane potential in left ventricle fragments from rats and rabbits.
    Richter R
    Pharmazie; 1982 Oct; 37(10):736. PubMed ID: 7178221
    [No Abstract]   [Full Text] [Related]  

  • 22. A concise synthesis of fusaric acid and (S)-(+)-fusarinolic acid.
    Song JJ; Yee NK
    J Org Chem; 2001 Jan; 66(2):605-8. PubMed ID: 11429837
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of fusaric (5-butylpicolinic) acid on the monosynaptic reflex neural activity of cat spinal cord.
    Watanabe Y; Matsumiya T; Oka T
    Tokai J Exp Clin Med; 1981 Oct; 6(4):443-51. PubMed ID: 7324082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Psychotropic drugs as tools for clinical research into schizophrenia (author's transl)].
    Beckmann H
    Fortschr Neurol Psychiatr Grenzgeb; 1978 Oct; 46(10):564-77. PubMed ID: 29831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results of treatment of hypertension after renal transplantation: effects of converting enzyme inhibitor, angiotensin II analog, beta-blockade, and dopamine beta-hydroxylase inhibitor.
    Ochiai T; Watanabe K; Nishijima H; Hayashi R; Sato H; Takagi T; Mikami K; Nishikawa T; Tamura Y; Kumagai A
    Transplant Proc; 1980 Sep; 12(3):520-5. PubMed ID: 6261430
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of the novel dopamine beta-hydroxylase inhibitor SK&F 102698 on catecholamines and blood pressure in spontaneously hypertensive rats.
    Berkowitz BA; Arleth AJ; Sung CP; Kruse LI; DeWolf WE; Ohlstein EH
    J Pharmacol Exp Ther; 1988 Jun; 245(3):850-7. PubMed ID: 3385645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the basis for differences in serum DBH activity in immature and adult rats by use of homologous antibody.
    Grzanna R; Nelson MF; Weinshilboum RM; Dunnette J; Coyle JT
    J Neurochem; 1979 Oct; 33(4):913-21. PubMed ID: 39981
    [No Abstract]   [Full Text] [Related]  

  • 28. Dopamine-beta-hydroxylase inhibitors, feeding and locomotor activity: reinstatement of feeding following central norepinephrine.
    Evans KR; Beninger RJ; Eikelboom R
    Pharmacol Biochem Behav; 1985 Apr; 22(4):535-40. PubMed ID: 3991764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of food intake by a noradrenergic system using clonidine and fusaric acid in the neonatal chick.
    Bungo T; Shimojo M; Masuda Y; Choi YH; Denbow DM; Furuse M
    Brain Res; 1999 May; 826(2):313-6. PubMed ID: 10224312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of dopamine-b-hydroxylase in manic patients. A clinical trial and fusaric acid.
    Sack RL; Goodwin FK
    Arch Gen Psychiatry; 1974 Nov; 31(5):649-54. PubMed ID: 4613319
    [No Abstract]   [Full Text] [Related]  

  • 31. Synthesis of 5-(substituted alkyl) picolinic acids. The dopamine beta-hydroxylase inhibitors. II.
    Miyano K; Sakasai T; Hamano H
    Chem Pharm Bull (Tokyo); 1978 Aug; 26(8):2328-33. PubMed ID: 709695
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies on the interaction of Cibacron Blue and Procion Red with dopamine beta-monooxygenase.
    Skotland T
    Biochim Biophys Acta; 1981 Jun; 659(2):312-25. PubMed ID: 7260097
    [No Abstract]   [Full Text] [Related]  

  • 33. NIH conference. Dopamine- -hydroxylase. Basic and clinical studies.
    Kopin IJ; Kaufman S; Viveros H; Jacobowitz D; Lake CR; Ziegler MG; Lovenberg W; Goodwin FK
    Ann Intern Med; 1976 Aug; 85(2):211-23. PubMed ID: 782312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Substituted picolinic acids as DBH inhibitors. Inhibition of dopamine beta-hydroxylase and antihypertensive action].
    Piesche L; Hilse H; Oehlke J; Schrötter E; Oehme P
    Pharmazie; 1983 May; 38(5):335-8. PubMed ID: 6611632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catecholamine content and in vitro catecholamine synthesis in peripheral human lymphocytes.
    Musso NR; Brenci S; Setti M; Indiveri F; Lotti G
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3553-7. PubMed ID: 8855800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nucleus tractus solitarius: an evaluation by in vivo voltammetry.
    Bhaskaran D; Freed CR
    Life Sci; 1987 Jul; 41(3):323-31. PubMed ID: 2885706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine-beta-hydroxylase in nerve function and mental illness.
    Brown FC; Coleman JH
    Dis Nerv Syst; 1975 Jul; 36(7):383-5. PubMed ID: 1097223
    [No Abstract]   [Full Text] [Related]  

  • 38. Indirect and direct inhibition of dopamine beta-hydroxylase by amphetamine in storage vesicles and synaptosomes.
    Lau C; Slotkin TA
    Br J Pharmacol; 1976 Jun; 57(2):223-8. PubMed ID: 779909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Developmental toxic effects of fusaric acid in CD1 mice.
    Reddy RV; Larson CA; Brimer GE; Frappier BL; Reddy CS
    Bull Environ Contam Toxicol; 1996 Sep; 57(3):354-60. PubMed ID: 8672059
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacological action of FD-008, a new dopamine beta-hydroxylase inhibitor. I. Effects on blood pressure in rats and dogs.
    Ishii Y; Fujii Y; Mimura Ch; Umezawa H
    Arzneimittelforschung; 1975 Jan; 25(1):55-9. PubMed ID: 1173769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.